Full-Time
Non-invasive cardiac monitoring platform using AI
No salary listed
Senior
Chicago, IL, USA + 1 more
More locations: Research Triangle, Durham, NC, USA
Candidates must be located in or willing to relocate to the Chicago, IL area or Raleigh-Durham, NC area. This position may require 10-20% travel depending on the candidate's location.
Get referrals →
You have ways to get a Cardiosense referral from your network.
Applications through a referral are 3x more likely to get an interview!
Upload your resume to see how it matches 12 keywords from the job description.
PDF, DOC, DOCX, up to 4 MB
Cardiosense develops a non-invasive monitoring platform designed to enhance cardiac care through advanced technology. The platform utilizes biometric sensors and artificial intelligence to analyze the electromechanical behavior of heartbeats, providing early warnings of declining heart function. This allows healthcare providers to identify at-risk patients and implement timely interventions. Unlike traditional methods that require invasive procedures, Cardiosense's solution is safer and easier for continuous patient monitoring. The company targets hospitals and clinics, generating revenue through the sale of wearable devices and subscription-based access to its analytics platform. The goal is to deliver actionable insights that enable healthcare teams to prevent severe cardiac events and improve patient recovery outcomes.
Company Size
11-50
Company Stage
Series A
Total Funding
$15.1M
Headquarters
Chicago, Illinois
Founded
2020
Help us improve and share your feedback! Did you find this helpful?
Hybrid Work Options
Relocation Assistance
Cardiosense Receives $15.1M Series A Round Back to HomeCHICAGO, IL, Cardiosense announced that it has raised $15.1 million in Series A funding.Cardiosense, a digital health company leveraging artificial intelligence and multi-sensor devices to enable early detection of cardiovascular disease, announced today that it has raised $15.1 million in Series A funding, co-led by Broadview Ventures and Hatteras Venture Partners, with participation from Laerdal Million Lives Fund, OSF Ventures, UnityPoint Health Ventures, and Portal Innovations. The capital will be used to support team expansion, accelerate product development, and fund an expansive heart failure study.Cardiosense is building a physiological waveform AI platform to develop predictive biomarkers to detect and manage cardiac disease. The Company has developed a suite of novel digital tools, multi-sensor devices, and analysis algorithms to detect early signs of cardiovascular disease, inform personalized therapy, and improve patient outcomes.(c)2011-2020 by Massinvestor, Inc. For contact info, please check out our about page